Introduction
Id-1 is a family member of the helix-loop-helix (HLH) transcription inhibitors and has been shown to inhibit cell differentiation, stimulate proliferation and facilitate tumor neoangiogenesis (Perk et al., 2005) . Although the expression of Id-1 is low in quiescent cells, it is required for G 1 to S cell-cycle progression in response to mitogenic signals (Barone et al., 1994; Hara et al., 1994) . Ectopic expression of Id-1 delays the onset of replicative senescence and prolongs the life span of primary fibroblasts (Alani et al., 1999; Nickoloff et al., 2000; Tang et al., 2002) . This positive effect of Id-1 on cell proliferation is suggested to regulate through its negative effect on the RB/p16
INK4a pathway (Alani et al., 2001; Ohtani et al., 2001; Zheng et al., 2004) . Id-1 has also been reported to play a key role in promoting cancer cell proliferation, survival and metastasis through activation of several oncogenic pathways such as mitogen-activated protein kinase, nuclear transcription factor-kB and Jun N-terminal kinase pathways (Ling et al., 2002 (Ling et al., , 2003 Zhang et al., 2006) , suggesting its positive effect in cancer development and progression. Suppression of Id-1 expression, on the other hand, has been shown to promote apoptosis (Zhang et al., , 2007 and inhibit metastatic progression (Fong et al., 2003) of cancer cells. In addition, upregulation of Id-1 has been reported in over 20 types of human cancer specimens (Wong et al., 2004) and its expression levels are positively correlated with advanced disease and poor prognosis in breast cancer , ovarian cancer , prostate cancer Yuen et al., 2006; Forootan et al., 2007) . These results further indicate that Id-1 is a potential oncogene. Recently, it has been reported that overexpression of Id-1 in primary human foreskin keratinocytes leads to centrosome amplification (Hasskarl et al., 2004) , a key step in the development of chromosomal instability. In addition, Id-2, another member of the Id protein family, has been reported to physically interact with APC Cdh1 in regulation of axonal growth through the D-box region (Lasorella et al., 2006) . Since the D-box region is also present in Id-1, and chromosomal instability is one of the most frequently reported characteristics of cancer cells, we hypothesize that Id-1 may play a role in regulation of mitosis through its interaction with APC
Cdh1
. Therefore, the aim of this study was to investigate the function of Id-1 in mitotic checkpoint control and chromosomal instability. We found that Id-1 was able to promote mitotic progression through modification of the activity of anaphase promoting complex/cyclosome C (APC/C) by physically inter-acting with its two activators, Cdc20 and Cdh1, which led to promotion of mitosis progression and chromosomal instability.
Results

Effect of Id-1 on mitotic progression
To explore the function of Id-1 in mitosis, we transiently overexpressed Id-1 in HeLa cells (Figure 1a, left panel) and studied its role in mitosis. The cells were synchronized at G 1 phase by a double thymidine block, released and tested for Id-1, p21 Waf1a , cyclin B1 and Cdc20 expression. We found (Figure 1a , right panel) that in the Id-1 overexpressing cells, after thymidine block release, there was an increased accumulation of cyclin B1, and a corresponding decrease in p21
Waf1a expression (Supplementary Figure 1A) , suggesting that Id-1 promotes G 1 to S transition as previously reported (Barone et al., 1994; Hara et al., 1994) . In contrast, western blotting analysis on the Id-1 overexpressing cells released from a nocodazole block revealed an earlier degradation of cyclin B1 and securin, which was associated with increased p21 Waf1a , beginning at 2 h ( Figure 1b ; Supplementary Figure 1B) , suggesting that ectopic Id-1 expression induces an early mitotic exit. We also observed that Id-1 overexpression led to increased Cdc20 expression in response to thymidine or nocodazole block, respectively, indicating a higher Cdc20 levels during entry into and exit from mitosis ( Figure 1a , right panel; Figure 1b ; Supplementary  Figures 1A and B) .
Cell-cycle analysis also demonstrated a higher percentage of G 2 /M (Figure 1c , left panel) and G 1 phase cells (Figure 1c , right panel) in Id-1 overexpressing cells after releasing from a G 1 or a G 2 /M block, respectively, further suggesting that Id-1 promotes cell-cycle progression. Additional experiments on the HeLa cells transiently expressing different levels of Id-1 protein showed an association between Id-1 expression and increased cyclin B1 accumulation and decreased p21
Waf1a after released from thymidine block (Figure 1d, left panel) . On the other hand, after nocodazole release, increased Id-1 expression level was associated with a dose dependent cyclin B1 and securin degradation (Figure 1d, right panel) . These results demonstrate a positive role of Id-1 in regulating progression of mitosis.
Id-1 interacts with Cdc20 and RASSF1A, and promotes the activity of APC/C Cdc20 Mitotic progression is controlled by APC/C, and Cdc20 is required for its ability to recognize and interact with mitotic substrates such as cyclin B and securin leading to their ubiquitination (Peters, 2006) . Next, we studied if the effect of Id-1 on mitosis was mediated through its interaction with Cdc20. Vectors containing Cdc20-Flag and Id-1-HA were transfected into 293FT cells which were then treated with nocodazole for 14 h. After immunoprecipitation with an anti-Flag antibody, , and treated with nocodazole for 14 h. Immunoprecipitation was performed using an anti-Flag antibody and western blotting was carried out on immunoprecipitates or total cell lysate using antibodies against Flag, HA and Cdc27. Note that there is approximately 38±5% increase in cdc27 levels in lane 2 vs lane 1. Lower panel: HeLa cells were transfected with Id-1-Flag and treated with nocodazole for 14 h. Immunoprecipitation was performed using an anti-Flag antibody followed by western blotting on immunoprecipitates (lanes 3, 4) or total cell lysate (lanes 1, 2). (b) Id-1 interacts with RASSF1A and inhibits its binding to Cdc20. 293FT cells were transfected with RASSF1A-Flag and Id-1-HA, and immunoprecipitation was performed using an antibody against Flag. Western blotting was carried out on the immunoprecipitates or total cell lysate using antibodies against Flag, HA and Cdc20. About 2% of whole cell lysate was examined and approximately 33% of the IP materials was loaded in both (a) and (b). (c) Colocalization of Id-1 with b-tubulin, Cdc20 and RASSF1A during mitosis. Immunofluorescent staining was performed on HeLa cells using antibodies against b-tubulin, Cdc20 and RASSF1A. 4 0 ,6-Diamidino-2-phenylindole (DAPI) staining was performed to indicate cell nucleus. Photographs were taken under Â 400 magnifications. (d) Id-1 promotes cyclin B1 and securin degradation during mitosis. 293FT cells transfected with Id-1 or vector control (left panel) were treated with nocodazole for 14 h and then cycloheximide (CHX) for indicated time points (right panel). Expression of cyclin B and securin was examined by western blotting and quantified by densitometry as band intensity ratio to time 0 h Â 100. Each experiment was repeated three times and error bars indicate s.e. (e) Luciferase assay. The D-box-luc plasmid was cotransfected with siCon or siId-1 into HeLa cells. Cells were then treated with nocodazole for 14 h and luciferase activity was measured. Note that Si-Id-1 significantly increased the luciferase activity. Result represented data from three separate experiments with s.e. as the error bar. Immunoprecipitation was performed using an anti-Flag antibody followed by western blotting on immunoprecipitates (lanes 3, 4) or total cell lysate (lanes 1, 2). About 2% of whole cell lysate was examined in lanes 4-6, while approximately 33% of the IP materials were loaded in lanes 1-3. Note that there is approximately 41 ± 7% increase in cdc27 levels in lanes 2 vs 1. (b) Colocalization of Id-1 with Cdh1 in mitotic cells. Immunofluorescent staining was performed on HeLa cells using antibodies against Cdh1 and Id-1. DAPI staining was performed to indicate cell nucleus. (c) N terminus domain is essential for the interaction between Id-1, Cdc20 and Cdh1. Five Id-1 mutants (schematic structure is shown in Supplementary Figure 3C ), or wild-type Id-1 (WT-Id-1-Flag) was cotransfected, respectively with Cdc20-HA (left panels) or Cdh1-HA (right panels) into 293FT cells. Immunoprecipitation was performed using an anti-Flag antibody and western blotting was performed on immunoprecipitates (left) or total cell lystate (right) using antibodies against Flag and HA. Arrows indicate different Id-1 proteins. (d) Cycloheximide (CHX) assay on the degradation rate of Aurora A, Cyclin B1, securin and Id-1. Id-1 protects Cdc20 and Aurora A proteins from degradation. An Id-1 expression vector or the vector control was transfected into 293FT cells, respectively, and the cells were then treated with nocodazole for 14 h and followed by CHX treatment for indicated time points. Western blotting was performed using antibodies against Cdc20, Aurora A and Actin. (e) DN71-Id-1 mutant does not modify degradation of Cdc20, Aurora A, cyclin B1 or Securin proteins. 293FT cells were transfected with DN71-Id-1-Flag or vector control, and treated as described in (d). (f) Cdh1 induces Id-1 degradation. 293FT cells transfected with Cdh1 or vector control were treated with nocodazole for 14 h and then CHX for indicated time points. Expression of Cdh1 (left) and Id-1 (right) was examined by western blotting. Each experiment was repeated three times and quantitation analysis is shown in Supplementary Figure 4 .
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Id-1-HA was detected ( Figure 2a , left panel, lane 2; full gel is shown in Supplementary Figure 2A ), indicating a physical interaction between Id-1 and Cdc20. In addition, we also found that the Cdc27 level was higher in the Id-1 expressing cells (approximately 38 ± 5%; Figure 2a , lane 2 vs lane 1), suggesting an increased binding activity between Cdc20 and APC. Previously, RASSF1A, a tumor suppressor and a negative regulator of mitotic entry, was reported to bind to Cdc20 and suppress its binding to APC/C (Song et al., 2004) . In this study, immunoprecipitation experiments showed that the exogenous Id-1-HA was coprecipitated with Flag-RASSF1A in the 293FT cells transfected with both Id-1-HA and RASSF1A-Flag (Figure 2b , left panel, lane 2; full gel is shown in Supplementary Figure 2B) , suggesting a physical interaction between Id-1 and RASSF1A. Figure 2C) cells. In addition, the cycloheximide (CHX) treatment experiments also showed that the protein degradation rates of both cyclin B1 and securin were much higher in the Id-1 overexpressing cells after nocodazole treatment ( Figure 2d , right panel), indicating that Id-1 inhibits the stability of both proteins during mitosis. These results indicate that Id-1 may be able to promote the activity of APC
Cdc20
, possibly through its physical interaction with RASSF1A. To further confirm the essential role of binding between Id-1 and Cdc20 on ACP activity, we constructed a vector containing a DNA fragment encoding the first 119aa of the human Cyclin B protein (including the D-Box region) that is linked to the luciferase gene. The resulting pGL3-D-Box-Luc encodes a luciferase protein conjugated with the N terminus of cyclin B protein (including D-Box). Once the vector is expressed, the binding of APC cdc20 to the D-box will initiate degradation of the luciferase protein, which is then measured as a decrease in luciferase activity to indicate APC cdc20 activity. As shown in Figure 2e , we found that the knockdown of Id-1 by siRNA significantly increased the luciferase activity of the transfected cells, indicating that Id-1 promotes APC cdc20 activity on the degradation of its substrate, which leads to stabilization of the D-box-conjugated luciferase protein.
Id-1 interacts with Cdh1 and inhibits the ubiquitin ligase activity of APC/C Cdh1 Previously, it was reported that Id-2 was a substrate of APC
Cdh1
, and an interaction between Id-1 and APC Cdh1 was also suggested in the same study (Lasorella et al., 2006) . Therefore, next, we investigated if the interaction between Id-1 and APC Cdh1 played a role in regulating mitotic progression. As shown in Figure 3a , we confirmed the physical interaction between Id-1 and APC Cdh1 by immunoprecipitation and western blotting (Figure 3a ; complete gel pictures are shown in Supplementary Figure 3A) . We found that Id-1 protein was detected in the Cdh-1-Flag precipitates (Figure 3a , lane 2) in the cells cotransfected with Cdh-1-Flag and Id-1-HA. Meanwhile, we also confirmed that Id-1 can interact with the endogenous Cdh1 protein (Figure 3a , right panel). In addition, immunofluorescent staining experiments also demonstrated that Id-1 protein was costained with Cdh1in mitotic cells (Figure 3b ; results on interphase cells are shown in Supplementary Figure   3B ). These results suggest that Id-1 physically interacts with Cdh1. In addition, we also found that Cdc27 level was lower (approximately 41 ± 7%) in the Id-1 expressing cells (Figure 3a , lane 2 vs lane 1), indicating that Id-1 decreases the binding activity between Cdh1 and APC/C.
To study if the D-box domain of Id-1 was responsible for the interaction between Id-1 and Cdh1 as previously suggested (Lasorella et al., 2006) , we constructed five Id-1 mutants, DN20, 71 (20 or 71 amino acid deleted from N terminus with disruption of the HLH domain, respectively) and DC20, 60 (20 or 60 amino acids deleted from C terminus including D-box, respectively; detailed schematic structures are shown in Supplementary Figure  3C ) and cotransfected them into 293FT cells, respectively with Cdc20-HA (left panel) or Cdh1-HA (right panel). Immunoprecipitation experiments on Flag pulldown cell lysates (Figure 3c ) showed that both Cdc20 and Cdh1 were detected in the DC60-Id-1 mutant but not in the DN71-Id-1 transfectants. These results reveal that the N terminus of the Id-1 protein rather than the D-box domain is essential for the interaction between Id-1 and Cdh1. These results are unexpected since APC Cdh1 interacts with majority of its substrates through the D/KEN-Box domains (Peters, 2006) and the APC Cdh1 -induced Id-2 degradation is mediated through the D-box domain (Lasorella et al., 2006) . Previously, Cdc20 and Aurora A are demonstrated to be substrates of APC Cdh1 . During anaphase, APC Cdh1 binds to Cdc20 and induces its degradation, leading to activation of APC Cdh1 and mitotic exit (Peters, 2006) . The binding of Aurora A to APC Cdh1 , on the other hand, is thought to be essential for its destruction and subsequent mitotic exit (Crane et al., 2004) . To further study the effect of Id-1 and the DN71-Id-1 mutant on Cdc20 and Aurora A degradation, we transfected Id-1 and DN71-Id-1-Flag, as well as their corresponding control vectors into 293FT cells, respectively, and then performed CHX treatment assay after exposure to nocodazole. As shown in Figure 3d and Supplementary Figure 4A , both Cdc20 and Aurora A protein degradation rates were much slower in the Id-1 expressing cells compared to the vector control. In contrast, there was no notable difference in the Cdc20 and Aurora A protein levels between the cells expressing DN71-Id-1-Flag and the vector control (Figure 3e ; Supplementary Figure 4B ). In addition, there is no notable difference in the cyclin B1 and securin expression levels between the cells expressing DN71-Id-1-Flag. These results suggest that the N-terminal 71 amino acids are necessary for the binding of Id-1 to Cdh1 and its protection against Cdc20 and Aurora A degradation. Previously, it was suggested that Id-1 was a substrate of Cdh1 (Lasorella et al., 2006) , and in this study, we found that overexpression of Cdh1 in HeLa cells (Figure 3f , left panel) led to moderate decrease in Id-1 protein levels after CHX treatment ( Figure 3f , right panel; Supplementary  Figure 4C ), suggesting that Id-1 is also targeted for degradation by APC
. However, the Id-1 protein degradation rate was not proportional to the exogenous Cdh1 levels.
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Effect of Id-1 expression on chromosomal instability in response to microtubule disruption Deregulation of APC/C activity during mitosis leads to missegregation of chromosomes and aneuploidy. To study if overexpression of Id-1 could promote chromosomal instability, we then stably introduced an Id-1 expression vector into a HPV16 E6/E7 immortalized prostate epithelial cell line, NPTX (Figure 4a , top panel). Flow cytometric analysis showed (Figure 4a , bottom panel) that after being challenged with two microtubule disruptors, nocodazole (100 nM) and colcemid (0.2 mg/ml), both Id-1 overexpressing cells and the vector control showed an accumulation of a G 2 /M phase cells with a peak at 24 h postexposure time. However, both cell lines were able to overcome the G 2 /M arrest after extended exposure time to generate a population of cells with >4n DNA content (see arrows). Interestingly, the percentage of cells with >4n DNA content was much higher in the Id-1 overexpressing cells compared to the vector control especially after colcemid treatment, indicating that ectopic Id-1 expression promotes chromosomal instability. To confirm these results, we repeated these experiments on a pair of previously generated NPTX cell lines stably transfected with an antisense-Id-1 and the vector control, respectively ( These results suggest that Id-1 is able to promote chromosomal instability, possibly through promoting an early mitosis progression. Previously, overexpression of Id-1 was reported to induce centrosome amplification (Hasskarl et al., 2004) , a key step of aneuploidy. Next, we performed g-tubulin staining and analysed centrosome numbers in both Id-1 overexpressing and AS-Id-1 transfectants. As shown in Figure 5a , after exposure to nocodazole, Id-1 overexpression led to increased percentage of cells containing multiple centrosomes ( Figure 5a , left panel; Po0.05), while suppression of Id-1 expression resulted in reduction of cells containing multiple centrosomes ( Figure 5a , right panel; *Po0.05). However, unlike reported (Hasskarl et al., 2004) , we did not observed any significant difference in centrosome numbers between these cell lines without nocodazole treatment. To study if there was a differential expression of Cdc20 and Aurora A in the two pairs of transfectants, we performed western blotting after treatment with nocodazole. As shown in Figure 5b and Supplementary Figure 5A , the expression levels of both proteins were higher in the Id-1 overexpressing cells but much lower in the AS-Id-1 cells compared to their respective vector controls. These results further confirm previous results that Id-1 promotes stabilization of Cdc20 and Aurora A in HeLa cells (Figure 3d ). However, we did not observe any association between Id-1 expression and Cdc20, Aurora A or RASSF1A in the untreated cells either Role of Id-1 in regulation of mitosis X Wang et al transiently (HeLa) or stably transfected with Id-1 (NPTX; Figure 5c ; Supplementary Figure 5B ). In addition, there was also no notable difference in the mean number of chromosomes between the Id-1 overexpressing cells and the vector control (Figure 5d ).
Discussion
Controlling the activity of APC/C is important for preventing premature or improper ubiquitination and destruction of its substrates, which may lead to deregulation of mitosis and chromosomal instability (Peters, 2006) . Recently, several APC/C inhibitors have been identified, such as MAD2 (Li et al., 1997) , BUB1 (Tang et al., 2004) and more recently, RASSF1A (Song et al., 2004) . In this study, we revealed that Id-1 was a unique regulator of mitosis through interaction with both Cdc20 and Cdh1. During early mitosis, our results demonstrate Id-1 as a positive regulator of Cdc20 in regulation of mitotic progression. First, Id-1 physically interacts with Cdc20 and promotes its binding activity to APC (Figure 2a) . Second, Id-1 forms a complex with RASSF1A (Figure 2b ), an inhibitor of Cdc20 Role of Id-1 in regulation of mitosis X Wang et al (Song et al., 2004) , and prevents its binding to Cdc20. Third, overexpression of Id-1 promotes degradation of cyclin B1 and securin (Figure 2d) , two of the APC Cdc20 substrates, leading to premature progression of mitosis (Figure 1) . Fourth, as demonstrated in Figures 3a and d , the interaction between Id-1 and Cdh1 also led to Cdc20 stabilization, possibly as the result of its inhibitory effect on the binding activity between Cdh1 and APC and subsequent decreased E3 ubiquitin ligase activity to induce Cdc20 degradation. This hypothesis is supported by the results shown in Figure 3e that the Id-1 mutant DN71-Id-1-Flag was unable to promote Cdc20 stabilization or cyclin B1 and securin degradation. Previously, it was reported that in human cancer cells, overexpression of Cdc20 led to impairment of mitotic checkpoint, premature anaphase and aneuploidy (Mondal et al., 2007) . In this study, in response to microtubule disruption, cells with high levels of Id-1 failed to arrest at mitosis leading to aneuploidy. Suppression of Id-1, on the other hand, led to decrease of polyploidy ( Figure 4 ). It is reasonable to conclude that the Id-1-induced Cdc20 expression is one of the mechanisms leading to its activation and the subsequently premature mitosis. During late mitosis, activation of APC Cdh1 results in destruction of a series of substrates including Aurora A and plk1, which in turn activates separase, leading to chromosomal segregation and mitosis exit (Nakayama and Nakayama, 2006) . Suppression of APC Cdh1 activity, on the other hand, may lead to stabilization of these proteins, failure in cytokinesis, and polyploidy. In this study, our results suggest that Id-1 may mediate cytokinesis through inhibition of APC Cdh1 activity based on the following evidence. First, Id-1 binds directly to Cdh1 (Figure 3a) . However, unlike previously suggested in the Id-2 studies (Lasorella et al., 2006) , the D-box domain is not necessary for the physical interaction between Id-1 and Cdh1 (Figure 3c) . Instead, the N terminus with a disrupted HLH domain is crucial for the interaction between these two proteins. In agreement with our results, it was reported (Hasskarl et al., 2004) that deletion of 64 amino acids from the N terminus of the Id-1 protein abrogated the Id-1-induced centrosome amplification in human foreskin keratinocytes, while the truncation mutant with 44 amino acids deleted from C terminus showed similar results to the WT-Id-1 (Hasskarl et al., 2004) , suggesting that the functional integrity of the N-terminal portion is necessary for Id-1 to evoke chromosomal instability. Second, the binding of Id-1 to Cdh1 prevents it from forming complex with APC, therefore, inhibiting the E3 ubiquitin ligase activity of APC Cdh1 on Aurora A and Cdc20 degradation (Figures 3a and d; Supplementary Figure 4A ). In contrast, the DN71-Id-1 mutant which failed to bind Cdh1 is not able to protect Aurora A and Cdc20 degradation (Figures 3c and e; Supplementary Figure  4B ), suggesting that the interaction between Id-1 and Cdh1 plays a key role in suppressing its activity. Third, although our results (Figure 3f ; Supplementary Figure  4C ) and others' (Lasorella et al., 2006) suggest Id-1 is a APC Cdh1 substrate, overexpression of Cdh1 only induced moderate Id-1 degradation. In addition, Id-1 expression levels showed moderate alteration during entry or exit of mitosis (Figures 1a and b) . It is possible that the negative effect of Id-1 on APC Cdh1 is not mediated as a competitive substrate but an inhibitor of binding between Cdh1 and APC. However, further studies are necessary to establish this hypothesis. Fourth, it was reported that overexpression of Aurora A leads to polyploidy and centrosome amplification due to a defect in cytokinesis (Meraldi et al., 2002; Anand et al., 2003) . In this study, we have found that high Aurora A expression is positively correlated with Id-1 levels during progression to mitotic arrest (Figure 5b) , which was associated with polyploidy in response to microtubule disruption (Figure 4) . Although a previous study reported that Id-1 overexpression induced centrosome amplification (Hasskarl et al., 2004) , our evidence indicates that the increased centrosome numbers found in the Id-1 overexpressing cells may be the result of failed cytokinesis. Fifth, our results also suggest that the negative effect of Id-1 on APC Cdh1 may also contribute to its positive role on cell proliferation. The Id-1-induced premature APC Cdh1 inactivation during G 1 phase of the cell cycle may allow the accumulation of proteins such as cyclin B1 for DNA replication and early progression to mitosis. Although several pathways have been suggested to mediate the positive role of Id-1 in cell proliferation (Alani et al., 2001; Ohtani et al., 2001; Ling et al., 2002; Zheng et al., 2004) , in this study, the accumulation of cyclin B1 and downregulation of p21
Waf1a found in the Id-1 overexpressing cells after thymidine block release (Figure 1a ) may play a key role in promoting G 1 to S phase progression. This hypothesis is also supported by previous findings that Id-1 was negatively associated with p21
Waf1a and p27
kip1
, and positively associated with cyclin B expression in several cell types (Prabhu et al., 1997; Di et al., 2006) . Finally, it was reported that overexpression of Cdc20 in myeloid cells led to promotion of cell-cycle G 1 to S phase transition (Lin and Sakamoto, 2001) , suggesting that the increased Cdc20 expression in the Id-1 expressing cells in this study may also play a positive role on cell proliferation.
As discussed previously, the positive role of Id-1 in the development and progression of human cancer has been frequently reported on clinical specimens. For example, upregulation of Id-1 has been reported in more than 20 types of human cancer specimens (Wong et al., 2004; Perk et al., 2005) and its expression levels have been positively correlated with disease progression and poor outcome Schoppmann et al., 2003; Ling et al., 2006; Forootan et al., 2007) . As summarized in Figure 6 , the results generated from the current study support that Id-1 a positive regulator of mitosis through regulation of APC Cdc20 and APC Cdh1 and provide a molecular basis for its role as a potential oncogene by promoting mitotic defects. However, in this study, the evidence that Id-1 overexpression alone is not sufficient to induce centrosome amplification, aneuploidy, or alterations of Aurora A, Cdc20 expression (Figures 5a, c and d) suggests that Id-1 does not directly regulate the expression of these proteins. On the Role of Id-1 in regulation of mitosis X Wang et al other hand, as shown in results on nocodazolesynchronized cells, Id-1 was able to prevent Cdc20 and Aurora A protein degradation during mitotic exit (Figure 3 ), possibly through its interaction with cdh1 ( Figure 3) . These results indicate that like majority of mitotic regulators, Id-1 may function as a part of the mitotic checkpoint machinery only when it is activated, that is, by microtubule disruption, to promote premature mitosis and subsequent chromosomal instability.
Materials and methods
Cell culture
The human papilloma virus 16 E6/E7 immortalized human prostate epithelial cell line, NPTX, was kindly provided by Dr S Topalian (NCI, NIH, Bethesda, MD, USA) and cultured as previously described (Bright et al., 1997) . HeLa and 293FT cell lines were obtained from the American Tissue Culture Corporation (ATCC, Rockville, MD, USA) and grown in RPMI 1640 or Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, respectively. Double thymidine block: cells were treated with 2.5 mM thymidine (Sigma, St Louis, MO, USA) for 16 h, released for 8 h, and then treated again for 16 h. Nocodazole block: Cells were treated with 100 nM nocodazole (Sigma, St Louis, MO, USA) for 12 h. The floating cells were then harvested in culture medium with gentle shaking. ) to the D-box will initiate degradation of the luciferase protein, which is then measured as decreased luciferase activity to indicate APC cdc20 (or APC cdh1 ) activity.
Transfection
Stable Id-1 overexpressing transfectants of NPTX cells as well as the antisense Id-1 (AS-Id-1) transfectants were generated as previously described (Di et al., 2006) . Transient transfection was achieved using FuGENE HD transfection reagent (Roche Diagnostics, Indianapolis, IN, USA) according to the manufacture's recommendation.
Western blotting
Detailed experimental procedures were previously described (Di et al., 2006) . Details of primary antibodies used are as follows: Id-1 (C-20), actin (C-11), Aurora kinase A (H-130), securin (H-160), cyclin B1 (D-11) Cdc20 (H-7) (All from Santa Cruz Biotechnology, Santa Cruz, CA, USA), p21 and on the other hand suppress the activity of APC Cdh1 , which may eventually lead to failure in both mitotic arrest and cytokinesis.
Role of Id-1 in regulation of mitosis X Wang et al obtained from Sigma. Each experiment was repeated three times and representative results are shown. The results were quantified by densitometry scanning of each band with LabWorks Image Acquisition and Analysis Software (UVP, Cambridge, UK). The intensity ratio between Actin and the tested protein was generated which was defined as '1' at time 0 h for each experiment. Results shown are the average of three experiments and the error bars indicate s.e.
Immunoprecipitation
Immunoprecipitation was performed using the FLAG HA Tandem Affinity Purification Kit (Sigma). Briefly, cell lysates were incubated with anti-Flag M2 affinity resin or Anti-HA agarose affinity resin overnight. Then the resin was washed three times with lysis buffer. Afterward the complex on the anti-Flag M2 affinity resin was eluted with 3 Â FLAG peptide (150 ng/ml) or urea (8 M) for 30 min at 4 1C. The eluted complex was loaded onto a SDS-polyacrylamide gel for electrophoresis.
Karyotyping analysis
Metaphase spread was prepared as previously described (To-Ho et al., 2007) . Chromosome number of at least 50 metaphase cells was determined by light microscopy with Â 400 magnification.
Immunofluorescent staining
Cells were plated on chamber slides (Nalge Nunc International, Rochester, NY, USA) and fixed with cold methanol and permeated with 0.2% TritonX-100 in phosphate-buffered saline. After blocking with 1% bovine serum albumin, the slides were first incubated with a primary antibody at room temperature for 1 h, and then the corresponding tetramethyl rhodamine isothiocyanate conjugated (DAKO A/S, Glostrup, Denmark) or fluorescein isothiocyanate-conjugated antimouse secondary antibody (DakoCytomatin) at room temperature for 1 h. The antibody details are as follows: g-tubulin and b-tubulin (Sigma, 1:40 dilution), Id-1 (C-20, Santa Cruz Biotechnology 1:50 dilution), Aurora kinase A (H-130, Santa Cruz Biotechnology, 1:50 dilution), RASSF1a (ab23950, Abcam, 1:20 dilution), anti-Flag M2 (Sigma, 1:40 dilution). Slides were cover slipped in mounting medium containing 4 0 ,6-diamidino-2-phenylindole (0.2 mg/ml, DakoCytomatin) and visualized on a Zeiss Axiophot microscope (Carl Zeiss Inc., Thornwood, NY, USA). Cells were photographed using a Spot RT digital camera and associated software (Diagnostic Instrument, Sterling Heights, MI, USA) under Â 400 magnification.
Flow cytometry
Detailed experimental procedures were described previously (Di et al., 2006) .
